Ebixa and aspartate aminotransferase increased Patient Reports February 13, 2012

Ebixa Side Effects Report #4930904-2
Ebixa side effect was reported by a Health Professional from FRANCE on Feb 20, 2006. Male patient, 87 years of age, was diagnosed with dementia alzheimer's type and was treated with Ebixa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, malaise, septic shock. Ebixa dosage: 20 MG QD PO. During the same period patient was treated with MEMANTINE, MELLERIL DRESDEN, ASPIRIN, ENALAPRIL MALEATE, AMLODIPINE BESYLATE, NOOTROPYL. Patient recovered.

Ebixa Side Effects Report #5133965-3
Ebixa side effect was reported by a Health Professional from ITALY on Oct 02, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Ebixa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, ophthalmoplegia, strabismus. Ebixa dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.

Ebixa Side Effects Report #4719103-7
Ebixa side effect was reported by a Health Professional from GERMANY on June 27, 2005. Female patient, 77 years of age, was diagnosed with dementia alzheimer's type and was treated with Ebixa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation , brain scan abnormal, cardiac failure, cerebrovascular accident, cognitive disorder, dementia alzheimer's type, dysphasia. Ebixa dosage: 10 MG BID PO. During the same period patient was treated with REMINYL, OPTINATE, LANSOPRAZOLE, KALCIPOS, LEVAXIN, ZOPIKLON, CITALOPRAM. Patient was hospitalized. Patient recovered.

Ebixa Side Effects Report #5130091-4
Ebixa side effect was reported by a Health Professional from GERMANY on Oct 04, 2006. Male patient, 65 years of age, was diagnosed with dementia alzheimer's type and was treated with Ebixa. After drug was administered, patient experienced the following side effects: aggression, alanine aminotransferase increased, aspartate aminotransferase increased, atrioventricular block third degree, bradycardia, hypotension, hypothermia , lung disorder, oliguria. Ebixa dosage: 10 MG BID PO. During the same period patient was treated with RISPERDAL. Patient was hospitalized. Patient recovered.


Ebixa Side Effects Report #5141033-X
Ebixa side effect was reported by a Consumer or non-health professional from FRANCE on Oct 18, 2006. Male patient, 65 years of age, was diagnosed with dementia alzheimer's type and was treated with Ebixa. After drug was administered, patient experienced the following side effects: aggression, alanine aminotransferase increased, aspartate aminotransferase increased, atrioventricular block third degree, bradycardia, hypotension, hypothermia , lung disorder, oliguria. Ebixa dosage: 10 MG BID PO. During the same period patient was treated with RISPERDAL, EXELON, ATENOLOL, TIAPRIDAL. Patient was hospitalized. Patient recovered.

Ebixa Side Effects Report #5208034-4
Ebixa side effect was reported by a Health Professional from ITALY on Dec 22, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with Ebixa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral ventricle dilatation, diplopia, disorientation, dystonia , fibrosis, gamma-glutamyltransferase increased, mydriasis. Ebixa dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.

Ebixa Side Effects Report #5339247-9
Ebixa side effect was reported by a Health Professional from GERMANY on May 15, 2007. Female patient, 94 years of age, weighting 110.2 lb, was treated with Ebixa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, transaminases increased. Ebixa dosage: 20 MG QD PO. During the same period patient was treated with SEROQUEL, SALOSPIR, THYROHORMONE. Patient recovered.